Protagonist Therapeutics, Inc. - Common Stock (NQ:PTGX)
Price and Volume
Detailed Quote| Volume | 907,207 |
| Open | 84.24 |
| Bid (Size) | 82.15 (1,000) |
| Ask (Size) | 88.65 (100) |
| Prev. Close | 84.20 |
| Today's Range | 83.64 - 86.67 |
| 52wk Range | 33.70 - 93.25 |
| Shares Outstanding | 62,107,572 |
| Dividend Yield | N/A |
Top News
More NewsPerformance
| YTD |
+119.1%
|
+119.1%
|
| 1 Month |
+16.2%
|
+16.2%
|
| 3 Month |
+48.6%
|
+48.6%
|
| 6 Month |
+87.0%
|
+87.0%
|
| 1 Year |
+105.0%
|
+105.0%
|
More News
Read More
What 7 Analyst Ratings Have To Say About Protagonist Therapeutics ↗
October 28, 2025
Via Benzinga
Via The Motley Fool
Topics
Energy
Moody Aldrich Fully Exits 136K SKWD Shares Worth $7.8 Million ↗
October 23, 2025
Via The Motley Fool
Moody Aldrich Liquidates Entire Stake in PLMR Worth $8.2 Million ↗
October 21, 2025
Via The Motley Fool
Topics
Regulatory Compliance
2 Top Dividend Kings Every Income Investor Should Own ↗
October 20, 2025
Via The Motley Fool
Topics
Bonds
Johnson & Johnson's M&A Strategy Is the Real Story for Investors ↗
October 18, 2025
Via MarketBeat
FDA Adds New Warning For Johnson & Johnson's Cancer Cell Therapy ↗
October 13, 2025
Via Benzinga
Why Protagonist Therapeutics Stock Skyrocketed by Almost 30% Today ↗
October 10, 2025
Via The Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session ↗
October 10, 2025
Via Benzinga
Via Benzinga
Which stocks are experiencing notable movement on Friday? ↗
October 10, 2025
Via Chartmill
5 Analysts Assess Protagonist Therapeutics: What You Need To Know ↗
October 08, 2025
Via Benzinga
Demystifying Protagonist Therapeutics: Insights From 4 Analyst Reviews ↗
September 17, 2025
Via Benzinga
Johnson & Johnson, Protagonist Study Shows Superior Skin Clearance In Psoriasis Trials ↗
September 17, 2025
Via Benzinga
Frequently Asked Questions
Is Protagonist Therapeutics, Inc. - Common Stock publicly traded?
Yes, Protagonist Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Protagonist Therapeutics, Inc. - Common Stock trade on?
Protagonist Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Protagonist Therapeutics, Inc. - Common Stock?
The ticker symbol for Protagonist Therapeutics, Inc. - Common Stock is PTGX on the Nasdaq Stock Market
What is the current price of Protagonist Therapeutics, Inc. - Common Stock?
The current price of Protagonist Therapeutics, Inc. - Common Stock is 85.40
When was Protagonist Therapeutics, Inc. - Common Stock last traded?
The last trade of Protagonist Therapeutics, Inc. - Common Stock was at 11/21/25 04:00 PM ET
What is the market capitalization of Protagonist Therapeutics, Inc. - Common Stock?
The market capitalization of Protagonist Therapeutics, Inc. - Common Stock is 5.30B
How many shares of Protagonist Therapeutics, Inc. - Common Stock are outstanding?
Protagonist Therapeutics, Inc. - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>